Trade Setup
Buy Target $11.27 | Sell Target $12.83 |
Trailing Stop 20% |
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections in the United States.
